<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Carbon monoxide poisoning</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Carbon monoxide poisoning</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Carbon monoxide poisoning</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott Manaker, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Holly Perry, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michele M Burns, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michelle Ruha, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Carbon monoxide (CO) is an odorless, tasteless, colorless, nonirritating gas formed by hydrocarbon combustion. The atmospheric concentration of CO is generally below 0.001 percent, but it may be higher in urban areas or enclosed environments. CO binds to hemoglobin with much greater affinity than oxygen, forming carboxyhemoglobin (COHb) and resulting in impaired oxygen transport and utilization. CO can also precipitate an inflammatory cascade that results in central nervous system (CNS) lipid peroxidation and delayed neurologic sequelae.</p><p>CO poisoning will be reviewed here. A summary table to facilitate emergency management is provided  (<a class="graphic graphic_table graphicRef60672" href="/z/d/graphic/60672.html" rel="external">table 1</a>). Related topics include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/326.html" rel="external">"Hyperbaric oxygen therapy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/299.html" rel="external">"Cyanide poisoning"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2749.html" rel="external">"Overview of occupational and environmental health"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>CO poisoning is estimated to occur in 50,000 people annually in the United States, and non-fire-related smoke inhalation is responsible for most cases [<a href="#rid1">1</a>]. Analysis of aggregated national data from the United States supports an overall mortality of 1 to 3 percent, with a mortality rate that is higher for intentional poisoning than for inadvertent exposure [<a href="#rid2">2-5</a>]. There are approximately 1000 to 1300 deaths from CO poisoning annually [<a href="#rid1">1,6,7</a>]. Intentional CO poisoning accounts for two-thirds of deaths and inadvertent, non-fire related CO poisoning cause the rest [<a href="#rid6">6,8</a>]. </p><p>In contrast with intentional poisoning, unintended poisoning demonstrates both seasonal and regional variation, and occurs more frequently during the winter months in cold climates, most commonly from faulty furnaces [<a href="#rid9">9</a>]. An increase in CO poisoning has been reported to occur in the immediate aftermath of electrical power outages leading to increased use of portable, gasoline-powered generators. Generator misplacement indoors or proximate to home ventilation intake systems causes CO exposure and occasional fatalities [<a href="#rid10">10-12</a>]. </p><p class="headingAnchor" id="H1905335807"><span class="h1">SOURCES OF EXPOSURE</span><span class="headingEndMark"> — </span>CO is produced from incomplete combustion of fuels. Potential sources of CO include:</p><p class="bulletIndent1"><span class="glyph">●</span>Smoke inhalation from fires.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poorly functioning heating systems.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Improperly vented fuel-burning devices (eg, kerosene heaters, charcoal grills, camping stoves [<a href="#rid13">13,14</a>], gasoline-powered electrical generators [<a href="#rid10">10,15</a>]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Motor vehicles operating in poorly ventilated areas (eg, ice rinks, warehouses, parking garages, keyless cars left running, tailpipe blocked by snow drift).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Open air exposure to motorboat exhaust [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Underground electrical cable fires that produce large amounts of CO, which can seep into adjacent buildings and homes [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hookah (waterpipe) use [<a href="#rid18">18,19</a>]. (See  <a class="medical medical_review" href="/z/d/html/6916.html" rel="external">"Patterns of tobacco use", section on 'Waterpipes or hookahs'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inhaled or ingested methylene chloride (dichloromethane), an industrial solvent and a component of paint remover, is hepatically metabolized to CO and can cause CO toxicity in the absence of ambient CO [<a href="#rid20">20,21</a>]. In 2012, the European Union banned paint strippers containing methylene chloride, and in 2019, it was banned from all paint and coating removers for consumer use in the United States. However, methylene chloride may still be available in some products for industrial applications. (See  <a class="medical medical_review" href="/z/d/html/2749.html" rel="external">"Overview of occupational and environmental health"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>CO poisoning causes impaired oxygen delivery and utilization as well as generation of reactive oxygen species. CO diffuses rapidly across the pulmonary capillary membrane. Elimination is dependent upon the degree of oxygenation and, to a lesser extent, minute ventilation. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impaired oxygen delivery</strong> – CO<strong> </strong>binds to the iron moiety of heme (and other porphyrins) with approximately 240 times the affinity of oxygen forming carboxyhemoglobin (COHb). This induces an allosteric change that greatly diminishes the ability of the other three oxygen binding sites in hemoglobin to off-load oxygen to peripheral tissues  (<a class="graphic graphic_figure graphicRef111614" href="/z/d/graphic/111614.html" rel="external">figure 1</a>). This results in a deformation and leftward shift of the oxyhemoglobin dissociation curve, and compounds the impairment in tissue oxygen delivery  (<a class="graphic graphic_figure graphicRef50058" href="/z/d/graphic/50058.html" rel="external">figure 2</a>). The degree of carboxyhemoglobinemia is a function of the relative amounts of CO and oxygen in the environment, duration of exposure, and minute ventilation. (See  <a class="medical medical_review" href="/z/d/html/1623.html" rel="external">"Oxygen delivery and consumption"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impaired oxygen utilization</strong> – Approximately 10 to 15 percent of CO is extravascular and bound to molecules such as myoglobin, cytochromes, and NADPH reductase, resulting in impairment of oxidative phosphorylation at the mitochondrial level  (<a class="graphic graphic_figure graphicRef111615" href="/z/d/graphic/111615.html" rel="external">figure 3</a>) [<a href="#rid3">3,22</a>]. The half-life of CO bound to these molecules is longer than that of COHb. The importance of these nonhemoglobin-mediated effects has been best documented in the heart, where mitochondrial dysfunction due to CO can produce myocardial stunning despite adequate oxygen delivery [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1">CO also inactivates cytochrome oxidase in a manner similar to cyanide. CO and cyanide poisoning can occur simultaneously in patients following smoke inhalation, and their combined effects on oxygen transport and utilization appear to be synergistic [<a href="#rid24">24,25</a>]. (See  <a class="medical medical_review" href="/z/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reactive oxygen species</strong> – CO results in superoxide generation and oxidative stress, which likely contributes to lipid peroxidation and neurologic injury. (See <a class="local">'Delayed neuropsychiatric syndrome'</a> below.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL FINDINGS</span></p><p class="headingAnchor" id="H6"><span class="h2">Common symptoms</span><span class="headingEndMark"> — </span>The clinical findings of CO poisoning are highly variable and largely nonspecific [<a href="#rid26">26,27</a>]. Mildly or moderately CO-intoxicated patients often present with constitutional symptoms and may be misdiagnosed with acute viral syndromes [<a href="#rid28">28</a>]. In addition to current symptoms, the clinician should specifically inquire (of the patient and/or witnesses) about transient loss of consciousness, as the presence or absence of this finding is of critical importance in determining the need for hyperbaric oxygen (HBO). </p><p>In exposure calls to United States poison centers, patients who developed symptoms reported the following [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Headache: 58 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea: 33 percent </p><p class="bulletIndent1"><span class="glyph">●</span>Dizziness: 29 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Drowsiness: 14 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting: 14 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Cough/choking: 6 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Confusion: 5 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Shortness of breath: 5 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Syncope: 5 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Throat or eye irritation, chest pain, weakness: &lt;5 percent</p><p></p><p class="headingAnchor" id="H3282052344"><span class="h2">Examination findings</span><span class="headingEndMark"> — </span>In the absence of concurrent trauma or burns, physical findings in CO poisoning are usually confined to alterations in mental status, tachycardia, and tachypnea. Patients may manifest symptoms ranging from mild confusion to coma. There is no role for specific cognitive testing, such as the Carbon Monoxide Neuropsychological Screening Battery, in the acute setting [<a href="#rid20">20,29</a>]. </p><p>The classically described finding of a "cherry red" appearance of the lips is neither a sensitive nor specific sign [<a href="#rid26">26</a>]. </p><p class="headingAnchor" id="H864327783"><span class="h2">Severe toxicity</span><span class="headingEndMark"> — </span>CO poisoning is considered severe in patients with any of the following findings:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic</strong> – Seizures, syncope, transient loss of consciousness, or coma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic</strong> – Lactic acidosis (which may be profound) from cellular hypoxia and cytochrome oxidase inhibition.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular </strong>– Acute myocardial ischemia, myocardial injury, ventricular arrhythmias, and pulmonary edema. </p><p></p><p class="bulletIndent1">Myocardial ischemia is common among moderately to severe CO-poisoned patients and is associated with increased long-term mortality. A retrospective study of 230 patients with moderate or severe CO poisoning referred to a specialized center found evidence of myocardial ischemia (characteristic electrocardiographic changes or elevated serum cardiac biomarkers) in one-third of all cases [<a href="#rid30">30</a>]. (See <a class="local">'Long-term outcomes'</a> below.) </p><p></p><p class="headingAnchor" id="H8"><span class="h2">Delayed neuropsychiatric syndrome</span><span class="headingEndMark"> — </span>The syndrome of delayed neurologic sequelae (DNS) includes variable degrees of cognitive deficits, personality changes, movement disorders, and focal neurologic deficits. DNS occurs in 15 to 40 percent of patients with significant CO exposure [<a href="#rid6">6</a>]. DNS is reported to arise 3 to 240 days after apparent recovery, generally occurring within 20 days of CO poisoning. Deficits may persist for a year or longer [<a href="#rid31">31-34</a>]. </p><p>Although DNS is associated with abnormalities in the globus pallidus and deep white matter on computed tomography (CT), magnetic resonance imaging (MRI), and positron-emission tomography (PET), these findings are typically not found at acute presentation [<a href="#rid32">32,35-39</a>]. Hemorrhagic infarction of the globus pallidus and, less frequently, the deep white matter have been reported rarely following acute intoxication [<a href="#rid40">40</a>]. </p><p>The development of DNS correlates poorly with carboxyhemoglobin (COHb) levels, although the majority of cases are associated with loss of consciousness during acute intoxication [<a href="#rid3">3,20,41</a>]. The mechanism of DNS is incompletely understood, but it probably involves lipid peroxidation by reactive oxygen species generated by xanthine oxidase. Xanthine oxidase is produced in situ from xanthine dehydrogenase via enzymes released by white blood cells that adhere to damaged endothelial cells [<a href="#rid29">29,42-45</a>]. During recovery from CO exposure, events analogous to ischemia-reperfusion injury and exposure to hyperoxia may exacerbate the initial oxidative damage [<a href="#rid28">28,46</a>]. </p><p class="headingAnchor" id="H9"><span class="h1">DIAGNOSIS</span></p><p>The diagnosis of CO poisoning should be suspected in fire victims, in patients with flu-like symptoms in cold climates, especially if any other cohabitants or pets are also feeling ill, and patients with unexplained altered mental status or lactic acidosis. History obtained by emergency management personnel or ambient CO levels measured by the fire department may suggest CO poisoning. However, the ambient CO reading obtained by fire departments is often lower than the patient's exposure because emergency dispatchers (ie, 9-1-1 operators) often advise patients to open their windows.</p><p>The diagnosis of CO poisoning is made in patients with known or suspected CO exposure in conjunction with an elevated carboxyhemoglobin (COHb) level measured by cooximetry of a blood gas sample. In hemodynamically stable patients, venous samples are accurate and commonly used [<a href="#rid47">47,48</a>]. Nonsmokers may have up to 3 percent COHb at baseline; smokers may have levels of 10 percent [<a href="#rid20">20</a>]. Levels above these respective values are consistent with CO poisoning.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>COHb levels confirm exposure but may not tell extent</strong> – A COHb measurement is essential for determining exposure, but levels correlate imprecisely with the degree of poisoning. This is especially true if significant time has passed between exposure and when the level was obtained, owing to physiologic clearance of CO (see <a class="local">'Pathophysiology'</a> above). Any abnormally elevated COHb level associated with major symptoms (eg, loss of consciousness, altered mental status, cardiac ischemia) should be considered severe poisoning. Patient symptoms and signs guide management, <strong>not</strong> COHb level.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standard pulse oximetry is not useful</strong> – Standard pulse oximetry (SpO<sub>2</sub>) <strong>cannot</strong> screen for CO exposure, as it does not differentiate COHb from oxyhemoglobin  (<a class="graphic graphic_figure graphicRef65554" href="/z/d/graphic/65554.html" rel="external">figure 4</a>) [<a href="#rid49">49,50</a>]. Eight-wavelength pulse oximeters measuring COHb and methemoglobin are available but are not considered accurate enough to substitute for blood co-oximetry, although they may have a role as a screening test [<a href="#rid51">51-54</a>]. (See  <a class="medical medical_review" href="/z/d/html/1612.html" rel="external">"Pulse oximetry", section on 'Carboxyhemoglobin'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hydroxocobalamin</strong><strong> interferes with COHb measurement</strong> – Treatment with <a class="drug drug_general" data-topicid="8813" href="/z/d/drug information/8813.html" rel="external">hydroxocobalamin</a> (which could be administered prehospital for presumed cyanide exposure) can interfere with the measurement of COHb leading to inaccurate results, and both falsely low and elevated levels are reported [<a href="#rid55">55-59</a>]. In patients with possible cyanide exposure (eg, brought to the hospital from a fire), clinicians assuming care should ask whether hydroxocobalamin was given. However, regardless of such treatment, clinicians should make a presumptive diagnosis of CO poisoning on the basis of the exposure history and should err on the side of treatment with oxygen and hyperbaric oxygen (HBO) if there is any doubt. If available, blood samples obtained before treatment with hydroxocobalamin would provide more accurate measurements. </p><p></p><p class="headingAnchor" id="H2659103924"><span class="h1">POSTDIAGNOSTIC TESTING</span><span class="headingEndMark"> — </span>The following tests are obtained selectively after diagnosis of CO poisoning:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocardiogram (ECG) </strong>– Obtain in all symptomatic patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac biomarkers </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with ECG evidence of ischemia.</p><p class="bulletIndent2"><span class="glyph">•</span>Patients with cardiac risk factors or a history of cardiac disease [<a href="#rid30">30</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood gas </strong>–<strong> </strong>Patients who are critically ill should undergo blood gas testing. Arterial sample is preferred if there are signs of severe hypoperfusion; otherwise, a venous sample is adequate.</p><p></p><p class="bulletIndent1">Blood PO<sub>2</sub> measurements tend to be normal because PO<sub>2</sub> reflects O<sub>2</sub> dissolved in blood, and this process is not affected by CO. In contrast, hemoglobin-bound O<sub>2</sub> (which normally comprises 98 percent of arterial O<sub>2</sub> content) is profoundly reduced in the presence of carboxyhemoglobin (COHb). (See  <a class="medical medical_review" href="/z/d/html/1623.html" rel="external">"Oxygen delivery and consumption"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complete blood count (CBC), serum chemistries</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urine or serum pregnancy test</strong> – In females of child-bearing age. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiograph</strong> – Patients with dyspnea or hypoxia to evaluate for pulmonary edema.</p><p></p><p class="headingAnchor" id="H10"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H1724948992"><span class="h2">General principles</span></p><p class="bulletIndent1"><span class="glyph">●</span>The key interventions in the management of the CO-poisoned patient are prompt removal from the source of CO and provision of high-flow oxygen. (See <a class="local">'High-flow oxygen'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In cases of unintentional CO poisoning, the clinician must consider that other people could have ongoing CO exposure if the source is not identified and corrected. Local fire departments or other emergency management personnel can assist with an assessment of ambient CO levels in the suspected environment and removal of victims [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Small, critical access hospitals may lack the ability to measure carboxyhemoglobin (COHb) concentrations [<a href="#rid60">60</a>]. Patients suspected of CO poisoning who are treated in hospitals without on-site cooximetry should be started on 100 percent oxygen via nonrebreathing face mask. After initial stabilization, clinicians should discuss transfer with a medical toxicologist or a hyperbaric oxygen (HBO) specialist at a receiving hospital, especially for patients at high risk for adverse outcomes (eg, acidemia, ischemic electrocardiogram [ECG] changes, syncope, altered mental status, or persistent chest pain). The receiving facility should be capable of providing accurate measurement of COHb levels, ongoing intensive care, and HBO therapy. </p><p></p><p class="headingAnchor" id="H791950603"><span class="h3">High-flow oxygen</span><span class="headingEndMark"> — </span>In a patient with suspected or confirmed CO poisoning, we recommend initial treatment with high-flow (100 percent) normobaric oxygen via nonrebreathing face mask, regardless of pulse oximetry or arterial PO<sub>2</sub>. Elimination of CO starts once the patient is removed from the exposure and is almost exclusively via the pulmonary circulation through competitive binding of hemoglobin by oxygen. The half-life of COHb in a patient breathing room air is approximately 250 to 320 minutes; this decreases to 75 to 90 minutes with high-flow oxygen (&gt;15 L/minute) provided via a nonrebreathing mask [<a href="#rid61">61</a>]. Normobaric high-flow oxygen therapy is relatively safe and available, and it hastens the elimination of COHb even though evidence does not exist that, compared with breathing room air, supplemental oxygen actually limits or prevents delayed neuropsychiatric syndrome (DNS). In a trial of CO-poisoned patients, six-week cognitive sequelae were lower in patients who were treated with normobaric oxygen compared with patients not receiving supplemental oxygen (41 [60/146] versus 53 [9/17] percent), but this finding did not achieve statistical significance [<a href="#rid62">62</a>].</p><p class="headingAnchor" id="H2127735479"><span class="h2">Approach to patients with severe toxicity or critical illness</span></p><p class="headingAnchor" id="H11"><span class="h3">ABC's</span><span class="headingEndMark"> — </span>Initial management starts with assessing and stabilizing airway, breathing, and circulation. Patients who are comatose, have severely impaired mental status, or who do not have sufficient respiratory effort should be intubated without delay and mechanically ventilated using 100 percent oxygen. A summary table to facilitate emergent management is provided  (<a class="graphic graphic_table graphicRef60672" href="/z/d/graphic/60672.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3342329057"><span class="h3">Patients with smoke inhalation</span><span class="headingEndMark"> — </span>In patients suffering from CO poisoning from a fire or smoke inhalation who are critically ill (ie, those with coma, seizure, or hemodynamic compromise associated with a metabolic acidosis and increased blood lactate concentration), we recommend empiric administration of <a class="drug drug_general" data-topicid="8813" href="/z/d/drug information/8813.html" rel="external">hydroxocobalamin</a> to treat possible cyanide toxicity. Since cyanide exposure can occur from fires and smoke inhalation and there is overlap in clinical presentation with CO, it is difficult to definitively exclude concomitant cyanide toxicity, which can further impair tissue oxygen utilization and exacerbate cellular hypoxia [<a href="#rid22">22,63</a>]. The hydroxocobalamin dose is 70 mg/kg intravenous (IV; 5 g is the standard adult dose) and can be repeated after 10 to 15 minutes if the patient does not have rapid clinical improvement. Emergency medicine services may have administered hydroxocobalamin en route to the hospital. (See  <a class="medical medical_review" href="/z/d/html/299.html" rel="external">"Cyanide poisoning", section on 'Empiric treatment for smoke inhalation'</a> and  <a class="medical medical_review" href="/z/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>.) </p><p class="headingAnchor" id="H1884832241"><span class="h3">Hyperbaric oxygen therapy</span><span class="headingEndMark"> — </span>In patients with symptoms consistent with severe CO toxicity, we suggest treatment with HBO  (<a class="graphic graphic_algorithm graphicRef59259" href="/z/d/graphic/59259.html" rel="external">algorithm 1</a>). (See <a class="local">'Severe toxicity'</a> above.)</p><p>We use HBO in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>COHb level &gt;25 percent </p><p class="bulletIndent1"><span class="glyph">●</span>COHb level &gt;15 percent in a pregnant patient (see <a class="local">'Pregnant patients'</a> below) </p><p class="bulletIndent1"><span class="glyph">●</span>Loss of consciousness </p><p class="bulletIndent1"><span class="glyph">●</span>Severe metabolic acidosis (pH &lt;7.25) </p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of end-organ ischemia (eg, ECG changes, elevated cardiac biomarkers, respiratory failure, focal neurologic deficit, or altered mental status) </p><p></p><p>HBO provides the greatest benefit if treatment begins as early as possible, ideally within six hours, to increase elimination of the carboxyhemoglobinemia and improve tissue oxygenation [<a href="#rid64">64,65</a>]. Importantly, even if COHb has decreased to below the recommended thresholds noted above, delayed HBO treatment may still provide benefit; however, it is unproven if more than 24 hours has passed after CO exposure. All patients selected to receive HBO should have at least one treatment at 2.5 to 3 atmospheres absolute (ATA) as soon as possible to reverse the acute effects of CO intoxication, with possible additional therapy directed toward limitation or prevention of DNS [<a href="#rid20">20,24,30,66</a>]. </p><p>HBO exposes patients to 100 percent oxygen under supra-atmospheric conditions, which decreases the half-life of COHb to 30 minutes from approximately 75 to 90 minutes on 100 percent normobaric oxygen. The amount of oxygen dissolved in the blood also rises from approximately 0.3 to 6 mL per dL, which substantially increases the delivery of nonhemoglobin-bound oxygen to the tissues. HBO inhibits neutrophil oxidative burst, xanthine oxidase production, and lipid peroxidation, which is the purported mechanism of preventing DNS [<a href="#rid67">67,68</a>]. The mechanisms of action of HBO are discussed in more detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/326.html" rel="external">"Hyperbaric oxygen therapy", section on 'Mechanisms of action'</a>.)</p><p>Although we routinely advocate for HBO therapy in patients with a COHb level greater than 25 percent, we recognize that other clinicians may disagree based on their interpretation of existing studies. Some societies use 40 percent as the appropriate threshold. There is no clear basis in the medical literature for choosing one level over the other. Experts have created a broad set of indications for HBO therapy in CO-poisoned patients, despite the uncertainty in identifying which patients will benefit from HBO treatment [<a href="#rid20">20,27,46,69,70</a>]. Consultation with a medical toxicologist, regional poison control center, or HBO specialist can be helpful with this decision. (See <a class="local">'Additional resources'</a> below.) </p><p class="headingAnchor" id="H3883426542"><span class="h4">Efficacy</span><span class="headingEndMark"> — </span>Evidence supporting the use of HBO is based on trials with significant limitations, observational studies, and mechanistic data. </p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mortality</strong> – HBO has been associated with decreased mortality after CO poisoning. In a retrospective national poison database study including over 25,000 patients with CO poisoning, patients who received HBO had lower mortality up to four years after treatment than those who did not (adjusted hazard ratio [aHR] 0.74, 95% CI 0.67-0.81) [<a href="#rid70">70</a>]. The benefit of HBO was most pronounced for patients with acute respiratory failure (aHR 0.45) and patients younger than 20 years of age (aHR 0.43). Among all patients undergoing HBO, those who received two or more HBO treatments had lower mortality than patients who received only one. </p><p></p><p class="bulletIndent2">However, this study has significant limitations in data granularity; the severity of poisoning and timing of HBO were not available and were not factored in the analysis. Thus, there may have been a selection bias in favor of HBO therapy if mildly injured patients were more likely to receive HBO while severely injured patients were deemed futile or were too unstable for transfer. Despite these limitations, it provides indirect support for HBO therapy in patients with altered mental status or other severe manifestations of poisoning such as severe metabolic acidosis or end-organ ischemia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Delayed neuropsychiatric syndrome (DNS)</strong> – HBO may be beneficial in preventing the late neurocognitive deficits associated with severe CO poisoning. The quality and results of clinical trials designed to assess the efficacy of HBO in reducing the severity of DNS have varied widely [<a href="#rid2">2,31,53,71-77</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A metanalysis of six published trials (one published only in abstract form) included 1335 patients randomized to either HBO or normobaric oxygen therapy (NBO) and who had outcomes recorded. A pooled analysis using a random effects model showed a trend towards fewer neurologic sequalae in the HBO group (29 versus 34 percent, odds ratio [OR] 0.78, 95% CI 0.54-1.12) [<a href="#rid77">77</a>]. However, these six trials employed heterogeneous HBO protocols, inclusion criteria, and outcome definitions, thus limiting the ability to draw conclusions. Some studies excluded patients without syncope, while others excluded those with syncope. The number of HBO treatments and protocols varied, with several trials using lower than the recommended 2.5 ATA. The definition and measurement of neurologic sequalae and duration of follow-up varied between trials. Only two of the trials were double-blinded with "sham dives" in a chamber, which is critical in reducing bias since main outcomes are patient-reported symptoms [<a href="#rid71">71,73</a>]. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The trial with arguably the best methodology randomized 152 patients within 24 hours of presentation to hyperbaric or NBO [<a href="#rid71">71</a>]. Both hyperbaric and control groups received treatment in a hyperbaric chamber, effectively blinding the therapy that a patient was receiving. Six weeks after presentation, cognitive sequelae were less common in the group treated with HBO (25 versus 46 percent, OR 0.39, 95% CI 0.2-0.78). This advantage of hyperbaric therapy in terms of neurologic performance was maintained at six months and one year following initial presentation. A major limitation was the disparity in severity of toxicity and baseline characteristics between groups. Patients in the NBO group had a higher rate of cerebellar dysfunction before treatment (15 versus 4 percent), which was associated with a higher incidence of cognitive sequelae. Also, patients randomized to NBO had longer duration to CO than those in the HBO group (mean CO exposure 22 versus 13 hours). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Another randomized, double-blinded trial of 191 patients referred to a tertiary center with CO poisoning during a two-year period failed to document benefit for patients who received HBO [<a href="#rid73">73</a>]. Rather, DNS and poor performance on neuropsychiatric tests after one month were more common among HBO-treated patients. However, one month follow-up was only 46 percent, making the results of this trial uninterpretable.</p><p></p><p class="headingAnchor" id="H1782534429"><span class="h4">Challenges</span></p><p class="bulletIndent2"><span class="glyph">•</span>Limited availability of hyperbaric chambers is a major impediment to the wider application of HBO in the management of CO poisoning. In the United States, approximately 250 hyperbaric facilities offer either single occupant ("monoplace") or multiple occupant ("multiplace") chambers. Information regarding the location of hyperbaric facilities can be accessed through the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.uhms.org%2F&amp;token=Yrx3yi7b83pql7MZushMAsT4S0426IFR7%2FMBnPyjWKw%3D&amp;TOPIC_ID=322" target="_blank">Undersea and Hyperbaric Medical Society</a> website or via the Divers Alert Network Emergency Hotline (1-919-684-9111) [<a href="#rid20">20</a>]. Outside of the United States, international poison control centers can be contacted to help locate the nearest HBO chamber. Contact information for poison centers around the world is provided separately. (See <a class="local">'Additional resources'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Since most hospitals do not have an HBO chamber, the benefit of HBO must be weighed against the risks and logistical challenges of transferring a patient, especially a critically ill patient who may require close bedside attention. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Victims of fires and smoke inhalation often have fluid requirements, hemodynamic instability, and airway issues necessitating frequent titration of therapies. Patients placed in an HBO chamber should be relatively stable since they cannot be removed quickly, as it takes time to depressurize. There should be no concern for dysrhythmias since electrical cardioversion or defibrillation cannot be performed in a chamber.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients who are in extremis and are too unstable to be moved to an HBO chamber, extracorporeal membrane oxygenation (ECMO) may be employed for rescue therapy if it is available at the treating hospital. Successful outcomes with both venovenous and venoarterial ECMO for severe CO poisoning have been reported [<a href="#rid78">78-81</a>]. (See  <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a>.) </p><p></p><p>The complications of HBO are discussed in more detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/326.html" rel="external">"Hyperbaric oxygen therapy", section on 'Complications'</a>.)<strong> </strong></p><p class="headingAnchor" id="H3334940926"><span class="h2">Approach to patients without severe/critical illness</span></p><p class="headingAnchor" id="H1513954396"><span class="h3">Pitfalls</span><span class="headingEndMark"> — </span>Some patients with CO exposure who appear clinically well should be considered to have severe toxicity if at any time during their intoxication they met criteria for HBO. (See <a class="local">'Hyperbaric oxygen therapy'</a> above.) </p><p>COHb measurement must be interpreted in the context of time since exposure ended because the COHb level is expected to decrease through pulmonary elimination over time. Patients who had transient loss of consciousness with a confirmed CO exposure could still benefit from HBO even if their COHb level does not reflect the extent of exposure when it occurred.</p><p class="headingAnchor" id="H2781903745"><span class="h3">High-flow oxygen</span><span class="headingEndMark"> — </span>In a patient with suspected or confirmed CO poisoning not requiring intubation or meeting the indications for HBO, we recommend treating with high-flow (100 percent) oxygen via nonrebreathing face mask. Oxygen is continued until the symptoms attributed to CO poisoning have resolved and the COHb level predicted based on the elimination half-life of 90 minutes with high-flow oxygen would be less than 10 percent. (See <a class="local">'High-flow oxygen'</a> above.)</p><p class="headingAnchor" id="H3556801780"><span class="h3">Disposition</span><span class="headingEndMark"> — </span>Patients who are not clinically ill and do not meet indications for HBO can typically be managed in the emergency department since most symptoms will resolve with high-flow oxygen. Serial COHb levels are generally unnecessary once the diagnosis of CO poisoning is established since symptoms as well as the initial COHb level are usually sufficient to guide management. The unlikely scenario of an oral ingestion of methylene chloride would be an exception to this rule.</p><p>Patients whose symptoms do not resolve, who demonstrate ECG or laboratory evidence of severe poisoning, or who have other medical or social cause for concern should be hospitalized. Obtain psychiatric assessment and determination of suicidality in patients with intentional CO poisoning. (See  <a class="medical medical_review" href="/z/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p class="headingAnchor" id="H3068749586"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H1933237387"><span class="h2">Pediatrics</span></p><p class="headingAnchor" id="H2469849107"><span class="h3">Symptoms</span><span class="headingEndMark"> — </span>In young children signs of CO poisoning may be more subtle and nonspecific than those in adults. Infants and toddlers may present with complaints such as fussiness and feeding difficulty as the sole manifestation of CO poisoning [<a href="#rid82">82</a>]. Young children may develop signs and symptoms of CO poisoning faster than older children and adults who experience the same exposure due to their higher oxygen utilization and higher minute ventilation. In contrast, older children have similar symptoms to adults, as they are able to verbalize when they have headache or nausea. </p><p>The incidence of delayed neurologic sequelae (DNS) in the pediatric population is reported between 3 and 17 percent (lower than that of adults) [<a href="#rid83">83-85</a>].</p><p class="headingAnchor" id="H651260151"><span class="h3">Diagnosis and management</span><span class="headingEndMark"> — </span>Young age does not alter the diagnosis and management of CO poisoning, and hyperbaric oxygen (HBO) treatment centers generally do not modify their approach to therapy based upon age. Authorities make theoretical arguments for both more or less aggressive treatment in young children, but there are no human studies to support changes in current recommendations. </p><p>When HBO is administered to young children, the following specific concerns must be addressed:</p><p class="bulletIndent1"><span class="glyph">●</span>Myringotomy should be performed in children with active otitis media who are younger than five years or who are unable to equalize their middle ear pressure [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It may be helpful to allow a family member to accompany a frightened child into the chamber.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When HBO is administered to an infant, keep the infant warm since hypothermia can easily develop.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital abnormalities must also be taken into account:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A chest radiograph should be obtained to detect congenital anomalies such as lobar emphysema, which could lead to a pneumothorax.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with unpalliated ductal dependent cardiac lesions should undergo HBO with caution as oxygen may precipitate duct closure. In most cases, such patients are poor candidates for HBO, and a pediatric cardiologist should be involved.</p><p></p><p class="headingAnchor" id="H2505075903"><span class="h2">Pregnant patients</span><span class="headingEndMark"> — </span>The threshold to use HBO in pregnant patients is lower because of the greater affinity and longer half-life of CO bound to fetal hemoglobin, the inability to substantially increase placental perfusion, and the direct effects of hypoxemia and acidosis on the fetus. A prospective, multicenter study of fetal outcome following accidental CO poisoning found no physical or neurobehavioral deficits in 31 infants who were exposed to CO in utero when their mothers suffered mild to moderate CO poisoning [<a href="#rid87">87</a>]. Severe maternal poisoning resulted in adverse outcomes in three of five patients treated with normobaric oxygen alone; HBO was used in two other cases, and those children did not demonstrate evidence of prenatal injury. Exposure to HBO does not seem to adversely affect the fetus, but the published experience is limited [<a href="#rid88">88,89</a>].</p><p>There is limited information on the characteristics of the fetal heart rate tracing of pregnant patients with CO poisoning in the third trimester. In the few cases with detailed reports, the initial tracing showed baseline fetal tachycardia of 160 to 190 beats per minute in three of four fetuses, and all four had minimal variability with no accelerations or decelerations [<a href="#rid90">90,91</a>]. After 60 to 90 minutes of maternal HBO therapy, all of the tracings became normal.</p><p class="headingAnchor" id="H32783068"><span class="h1">LONG-TERM OUTCOMES</span><span class="headingEndMark"> — </span>In patients who survive the initial poisoning, morbidity is primarily related to late neurocognitive impairment and persists in up to 40 percent of victims [<a href="#rid2">2,3</a>]. Significant CO poisoning may be associated with an increased risk of developing a subsequent seizure disorder [<a href="#rid92">92</a>]. The prognosis of patients who sustain hypoxic-ischemic brain injury from any cause, including severe CO poisoning, is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/4833.html" rel="external">"Hypoxic-ischemic brain injury in adults: Evaluation and prognosis", section on 'Prognosis based on clinical findings'</a>.)</p><p>Long-term mortality is increased if CO poisoning causes myocardial injury. Long-term follow-up (median 7.6 years) of a cohort of patients with moderate to severe CO poisoning who sustained acute myocardial injury noted a mortality rate of 24 percent [<a href="#rid93">93</a>]. Mortality among patients with myocardial injury was more than twice that of poisoned patients without evidence of such injury and was estimated to be triple the expected rate for a comparable non-poisoned cohort. This study population was young (mean age 47 years) and had a low incidence of established cardiac disease or cardiac risk factors, other than smoking. </p><p class="headingAnchor" id="H17"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>CO monitors equipped with alarms are relatively inexpensive, widely available, and potentially life-saving. The United States Consumer Product Safety Commission (CPSC) recommends that every home have a CO monitor equipped with an alarm; further information is available online <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cpsc.gov%2F&amp;token=F2fTJXWTbAdqtiUVhUGfESpeToaalVtVTAQywOEZeaQ%3D&amp;TOPIC_ID=322" target="_blank">www.cpsc.gov</a> or via their hotline (1-800-638-2772). Given the evidence that CO is capable of diffusing rapidly through standard wallboard and floorboard materials, we recommend that every home (even those without an obvious source of CO) be equipped with a CO monitor [<a href="#rid94">94</a>].</p><p class="headingAnchor" id="H13112121"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H1007716790"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H1501773958"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114014.html" rel="external">"Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse"</a>.)</p><p class="headingAnchor" id="H248866570"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/86018.html" rel="external">"Patient education: Carbon monoxide (CO) poisoning (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Introduction </strong>– Carbon monoxide (CO), an odorless, tasteless, colorless, nonirritating gas, is formed by incomplete hydrocarbon combustion. CO poisoning is common, potentially fatal, can lead to permanent neurologic effects, and is probably underdiagnosed because of its nonspecific flu-like clinical presentation. An algorithm and brief table to facilitate emergent management are provided  (<a class="graphic graphic_algorithm graphicRef59259" href="/z/d/graphic/59259.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef60672" href="/z/d/graphic/60672.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sources of exposure</strong> – CO poisoning is most common during winter in cold climates; in aftermath of natural disasters when portable, gasoline-powered generators are increasingly used; and in smoke inhalation and fire victims. Other potential sources of CO include poorly functioning heating systems, improperly vented fuel-burning devices (eg, kerosene heaters, charcoal grills, camping stoves, gasoline-powered electrical generators), motor vehicles operating in poorly ventilated areas, hookah (water pipe) smoking, and exposure to methylene chloride. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Sources of exposure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology</strong> – CO diffuses rapidly across the pulmonary capillary membrane and binds to the iron moiety of heme forming carboxyhemoglobin (COHb), which is less effective at tissue oxygen delivery. CO also interferes with mitochondrial oxygen utilization and increases lipid peroxidation in the central nervous system (CNS). (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong> – Common symptoms are nonspecific and include headache, malaise, nausea, and dizziness. Infants and toddlers may present with only fussiness and feeding difficulty. Symptoms of more severe poisoning include chest pain, dyspnea, syncope, and confusion. In the absence of concurrent trauma or burns, physical findings are usually confined to tachycardia, tachypnea, and alterations in mental status, ranging from mild confusion to seizures and coma. (See <a class="local">'Clinical findings'</a> above.)</p><p></p><p class="bulletIndent1">The syndrome of delayed neurologic sequelae (DNS) includes variable degrees of cognitive deficits, personality changes, movement disorders, and focal neurologic deficits and occurs in 15 to 40 percent of patients with significant CO exposure. (See <a class="local">'Delayed neuropsychiatric syndrome'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis of CO poisoning is made in patients with known or suspected exposure in conjunction with an elevated COHb level measured by cooximetry of a venous blood gas sample. COHb levels greater than three in nonsmokers and greater than 10 to 15 in smokers confirms the diagnosis. The diagnosis of CO poisoning should be suspected in fire victims, in patients with flu-like symptoms in cold climates especially if any other cohabitants or pets are also feeling ill, and patients with unexplained altered mental status or lactic acidosis. Importantly, CO levels <strong>do not</strong> necessarily correlate with the severity of poisoning. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Post-diagnostic testing</strong> – Obtain electrocardiogram (ECG), complete blood count (CBC), chemistries, blood gas, cardiac biomarkers as in  (<a class="graphic graphic_algorithm graphicRef59259" href="/z/d/graphic/59259.html" rel="external">algorithm 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management </strong>– Assess and stabilize airway, breathing, and circulation. Patients who are comatose, have severely impaired mental status, or who do not have sufficient respiratory effort should be intubated without delay and mechanically ventilated using 100 percent oxygen. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a patient with suspected or confirmed CO poisoning, we recommend initial treatment with 100 percent normobaric oxygen via nonrebreathing face mask, regardless of pulse oximetry or arterial PO<sub>2</sub> (<a class="grade" href="https:///uptodate/show/grade_3" rel="external">Grade 1C</a>). High-flow oxygen decreases the half-life of COHb. (See <a class="local">'High-flow oxygen'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with the following indications, we suggest treating with hyperbaric oxygen therapy (HBO) in addition to normobaric 100 percent oxygen (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>COHb level &gt;25 percent </p><p class="bulletIndent3"><span class="glyph">-</span>COHb level &gt;15 percent in pregnant patient </p><p class="bulletIndent3"><span class="glyph">-</span>Loss of consciousness </p><p class="bulletIndent3"><span class="glyph">-</span>Severe metabolic acidosis (pH &lt;7.25)</p><p class="bulletIndent3"><span class="glyph">-</span>Evidence of end-organ ischemia (eg, ECG changes, elevated cardiac biomarkers, respiratory failure, focal neurologic deficit or altered mental status) (see <a class="local">'Hyperbaric oxygen therapy'</a> above)</p><p></p><p class="bulletIndent2">HBO increases elimination of CO in the presence of elevated COHb and potentially prevents DNS.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients suffering from CO poisoning from a fire or smoke inhalation who are critically ill (ie, those with coma, seizure, or hemodynamic compromise associated with a metabolic acidosis and increased blood lactate concentration), we empirically treat possible cyanide toxicity with <a class="drug drug_general" data-topicid="8813" href="/z/d/drug information/8813.html" rel="external">hydroxocobalamin</a>. The dose is 70 mg/kg intravenous (IV; 5 g is the standard adult dose), and can be repeated after 10 to 15 minutes if the patient does not have rapid clinical improvement. (See <a class="local">'Patients with smoke inhalation'</a> above and  <a class="medical medical_review" href="/z/d/html/299.html" rel="external">"Cyanide poisoning", section on 'Empiric treatment for smoke inhalation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In cases of unintentional CO poisoning, the clinician must consider that other people could have ongoing CO exposure if the source is not identified and corrected. Local fire departments or other emergency management personnel can assist with an assessment of ambient CO levels in the suspected environment and removal of victims. (See <a class="local">'General principles'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disposition </strong>– Many patients with mild symptoms from an unintentional poisoning can be managed in an emergency department and safely discharged. Patients whose symptoms do not resolve, who demonstrate ECG or laboratory evidence of severe poisoning, or who have other medical or social cause for concern should be hospitalized. (See <a class="local">'Disposition'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shin M, Bronstein AC, Glidden E, et al. Morbidity and Mortality of Unintentional Carbon Monoxide Poisoning: United States 2005 to 2018. Ann Emerg Med 2023; 81:309.</a></li><li><a class="nounderline abstract_t">Tibbles PM, Perrotta PL. Treatment of carbon monoxide poisoning: a critical review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen. Ann Emerg Med 1994; 24:269.</a></li><li><a class="nounderline abstract_t">Hardy KR, Thom SR. Pathophysiology and treatment of carbon monoxide poisoning. J Toxicol Clin Toxicol 1994; 32:613.</a></li><li><a class="nounderline abstract_t">Hampson NB, Hauff NM. Risk factors for short-term mortality from carbon monoxide poisoning treated with hyperbaric oxygen. Crit Care Med 2008; 36:2523.</a></li><li><a class="nounderline abstract_t">Hampson NB. U.S. Mortality Due to Carbon Monoxide Poisoning, 1999-2014. Accidental and Intentional Deaths. Ann Am Thorac Soc 2016; 13:1768.</a></li><li><a class="nounderline abstract_t">Rose JJ, Wang L, Xu Q, et al. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. Am J Respir Crit Care Med 2017; 195:596.</a></li><li><a class="nounderline abstract_t">Hampson NB. Carbon monoxide poisoning mortality in the United States from 2015-2021. Clin Toxicol (Phila) 2023; 61:483.</a></li><li><a class="nounderline abstract_t">Sircar K, Clower J, Shin MK, et al. Carbon monoxide poisoning deaths in the United States, 1999 to 2012. Am J Emerg Med 2015; 33:1140.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Unintentional non-fire-related carbon monoxide exposures--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005; 54:36.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Carbon monoxide poisoning from hurricane-associated use of portable generators--Florida, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:697.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Monitoring poison control center data to detect health hazards during hurricane season--Florida, 2003-2005. MMWR Morb Mortal Wkly Rep 2006; 55:426.</a></li><li><a class="nounderline abstract_t">Cukor J, Restuccia M. Carbon monoxide poisoning during natural disasters: the Hurricane Rita experience. J Emerg Med 2007; 33:261.</a></li><li><a class="nounderline abstract_t">Thomassen Ø, Brattebø G, Rostrup M. Carbon monoxide poisoning while using a small cooking stove in a tent. Am J Emerg Med 2004; 22:204.</a></li><li><a class="nounderline abstract_t">Thurman JT, Leavitt R, Buchanan JT, et al. Carbon Monoxide Levels Produced by Propane/Isobutane Canister Stoves inside a Tent. Wilderness Environ Med 2023; 34:513.</a></li><li><a class="nounderline abstract_t">Hampson NB, Dunn SL. Carbon Monoxide Poisoning from Portable Electrical Generators. J Emerg Med 2015; 49:125.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Carbon monoxide poisonings resulting from open air exposures to operating motorboats--Lake Havasu City, Arizona, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:314.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Carbon monoxide releases and poisonings attributed to underground utility cable fires--New York, January 2000-June 2004. MMWR Morb Mortal Wkly Rep 2004; 53:920.</a></li><li><a class="nounderline abstract_t">Retzky SS. Carbon Monoxide Poisoning from Hookah Smoking: An Emerging Public Health Problem. J Med Toxicol 2017; 13:193.</a></li><li><a class="nounderline abstract_t">Nguyen V, Salama M, Fernandez D, et al. Comparison between carbon monoxide poisoning from hookah smoking versus other sources. Clin Toxicol (Phila) 2020; 58:1320.</a></li><li><a class="nounderline abstract_t">Ernst A, Zibrak JD. Carbon monoxide poisoning. N Engl J Med 1998; 339:1603.</a></li><li><a class="nounderline abstract_t">Chang YL, Yang CC, Deng JF, et al. Diverse manifestations of oral methylene chloride poisoning: report of 6 cases. J Toxicol Clin Toxicol 1999; 37:497.</a></li><li><a class="nounderline abstract_t">Vogel SN, Sultan TR, Ten Eyck RP. Cyanide poisoning. Clin Toxicol 1981; 18:367.</a></li><li><a class="nounderline abstract_t">Tritapepe L, Macchiarelli G, Rocco M, et al. Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning. Crit Care Med 1998; 26:797.</a></li><li class="breakAll">Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning, 2nd ed, Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J (Eds), Williams &amp; Wilkins, Baltimore 1997.</li><li><a class="nounderline abstract_t">Norris JC, Moore SJ, Hume AS. Synergistic lethality induced by the combination of carbon monoxide and cyanide. Toxicology 1986; 40:121.</a></li><li><a class="nounderline abstract_t">Harper A, Croft-Baker J. Carbon monoxide poisoning: undetected by both patients and their doctors. Age Ageing 2004; 33:105.</a></li><li><a class="nounderline abstract_t">Kao LW, Nañagas KA. Carbon monoxide poisoning. Emerg Med Clin North Am 2004; 22:985.</a></li><li><a class="nounderline abstract_t">Tomaszewski C. Carbon monoxide poisoning. Early awareness and intervention can save lives. Postgrad Med 1999; 105:39.</a></li><li><a class="nounderline abstract_t">Thom SR. Carbon monoxide-mediated brain lipid peroxidation in the rat. J Appl Physiol (1985) 1990; 68:997.</a></li><li><a class="nounderline abstract_t">Satran D, Henry CR, Adkinson C, et al. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 2005; 45:1513.</a></li><li><a class="nounderline abstract_t">Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995; 25:474.</a></li><li><a class="nounderline abstract_t">Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983; 40:433.</a></li><li><a class="nounderline abstract_t">Kwon OY, Chung SP, Ha YR, et al. Delayed postanoxic encephalopathy after carbon monoxide poisoning. Emerg Med J 2004; 21:250.</a></li><li><a class="nounderline abstract_t">Hampson NB, Little CE. Hyperbaric treatment of patients with carbon monoxide poisoning in the United States. Undersea Hyperb Med 2005; 32:21.</a></li><li><a class="nounderline abstract_t">Zagami AS, Lethlean AK, Mellick R. Delayed neurological deterioration following carbon monoxide poisoning: MRI findings. J Neurol 1993; 240:113.</a></li><li><a class="nounderline abstract_t">Teksam M, Casey SO, Michel E, et al. Diffusion-weighted MR imaging findings in carbon monoxide poisoning. Neuroradiology 2002; 44:109.</a></li><li><a class="nounderline abstract_t">Kim JH, Chang KH, Song IC, et al. Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. AJNR Am J Neuroradiol 2003; 24:1592.</a></li><li><a class="nounderline abstract_t">Chu K, Jung KH, Kim HJ, et al. Diffusion-weighted MRI and 99mTc-HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema. Eur Neurol 2004; 51:98.</a></li><li><a class="nounderline abstract_t">Moon JM, Chun BJ, Baek BH, Hong YJ. Initial diffusion-weighted MRI and long-term neurologic outcomes in charcoal-burning carbon monoxide poisoning. Clin Toxicol (Phila) 2018; 56:161.</a></li><li><a class="nounderline abstract_t">Finelli PF, DiMario FJ Jr. Hemorrhagic infarction in white matter following acute carbon monoxide poisoning. Neurology 2004; 63:1102.</a></li><li><a class="nounderline abstract_t">Seger D, Welch L. Carbon monoxide controversies: neuropsychologic testing, mechanism of toxicity, and hyperbaric oxygen. Ann Emerg Med 1994; 24:242.</a></li><li><a class="nounderline abstract_t">Thom SR, Bhopale VM, Fisher D, et al. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci U S A 2004; 101:13660.</a></li><li><a class="nounderline abstract_t">Goldbaum LR, Ramirez RG, Absalon KB. What is the mechanism of carbon monoxide toxicity? Aviat Space Environ Med 1975; 46:1289.</a></li><li><a class="nounderline abstract_t">Zhang J, Piantadosi CA. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 1992; 90:1193.</a></li><li><a class="nounderline abstract_t">Thom SR, Xu YA, Ischiropoulos H. Vascular endothelial cells generate peroxynitrite in response to carbon monoxide exposure. Chem Res Toxicol 1997; 10:1023.</a></li><li><a class="nounderline abstract_t">Weaver LK. Carbon monoxide poisoning. Crit Care Clin 1999; 15:297.</a></li><li><a class="nounderline abstract_t">Touger M, Gallagher EJ, Tyrell J. Relationship between venous and arterial carboxyhemoglobin levels in patients with suspected carbon monoxide poisoning. Ann Emerg Med 1995; 25:481.</a></li><li><a class="nounderline abstract_t">Lopez DM, Weingarten-Arams JS, Singer LP, Conway EE Jr. Relationship between arterial, mixed venous, and internal jugular carboxyhemoglobin concentrations at low, medium, and high concentrations in a piglet model of carbon monoxide toxicity. Crit Care Med 2000; 28:1998.</a></li><li><a class="nounderline abstract_t">Bozeman WP, Myers RA, Barish RA. Confirmation of the pulse oximetry gap in carbon monoxide poisoning. Ann Emerg Med 1997; 30:608.</a></li><li><a class="nounderline abstract_t">Tremper KK, Barker SJ. Pulse oximetry. Anesthesiology 1989; 70:98.</a></li><li><a class="nounderline abstract_t">Barker SJ, Curry J, Redford D, Morgan S. Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study. Anesthesiology 2006; 105:892.</a></li><li><a class="nounderline abstract_t">Roth D, Herkner H, Schreiber W, et al. Accuracy of noninvasive multiwave pulse oximetry compared with carboxyhemoglobin from blood gas analysis in unselected emergency department patients. Ann Emerg Med 2011; 58:74.</a></li><li><a class="nounderline abstract_t">American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Carbon Monoxide Poisoning:, Wolf SJ, Maloney GE, et al. Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Carbon Monoxide Poisoning. Ann Emerg Med 2017; 69:98.</a></li><li><a class="nounderline abstract_t">Sebbane M, Claret PG, Mercier G, et al. Emergency department management of suspected carbon monoxide poisoning: role of pulse CO-oximetry. Respir Care 2013; 58:1614.</a></li><li><a class="nounderline abstract_t">Livshits Z, Lugassy DM, Shawn LK, Hoffman RS. Falsely low carboxyhemoglobin level after hydroxocobalamin therapy. N Engl J Med 2012; 367:1270.</a></li><li><a class="nounderline abstract_t">Lee J, Mukai D, Kreuter K, et al. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med 2007; 49:802.</a></li><li><a class="nounderline abstract_t">Borron SW, Uhl W, Nolting A, Hostalek U. Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning. Ann Emerg Med 2007; 50:624.</a></li><li><a class="nounderline abstract_t">Baud F. Clarifications regarding interference of hydroxocobalamin with carboxyhemoglobin measurements in victims of smoke inhalation. Ann Emerg Med 2007; 50:625.</a></li><li><a class="nounderline abstract_t">Pace R, Bon Homme M, Hoffman RS, Lugassy D. Effects of hydroxocobalamin on carboxyhemoglobin measured under physiologic and pathologic conditions. Clin Toxicol (Phila) 2014; 52:647.</a></li><li><a class="nounderline abstract_t">Hampson NB, Scott KL, Zmaeff JL. Carboxyhemoglobin measurement by hospitals: implications for the diagnosis of carbon monoxide poisoning. J Emerg Med 2006; 31:13.</a></li><li><a class="nounderline abstract_t">Weaver LK, Howe S, Hopkins R, Chan KJ. Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest 2000; 117:801.</a></li><li><a class="nounderline abstract_t">Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med 2007; 176:491.</a></li><li><a class="nounderline abstract_t">Roderique JD, Josef CS, Feldman MJ, Spiess BD. A modern literature review of carbon monoxide poisoning theories, therapies, and potential targets for therapy advancement. Toxicology 2015; 334:45.</a></li><li><a class="nounderline abstract_t">Ziser A, Shupak A, Halpern P, et al. Delayed hyperbaric oxygen treatment for acute carbon monoxide poisoning. Br Med J (Clin Res Ed) 1984; 289:960.</a></li><li class="breakAll">Goulon M, Barois, Rapin M, et al. Carbon monoxide poisoning and acute anoxia due to breathing coal gas and hydrocarbons. J Hyperbar MEd 1986; 1:23. http://archive.rubicon-foundation.org/xmlui/handle/123456789/4302 (Accessed on October 06, 2011).</li><li><a class="nounderline abstract_t">Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ 1998; 317:1140.</a></li><li><a class="nounderline abstract_t">Schnittger V, Rosendahl K, Lind F, Palmblad J. Effects of carbon monoxide poisoning on neutrophil responses in patients treated with hyperbaric oxygen. J Investig Med 2004; 52:523.</a></li><li><a class="nounderline abstract_t">Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol 1993; 123:248.</a></li><li><a class="nounderline abstract_t">Hampson NB, Dunford RG, Kramer CC, Norkool DM. Selection criteria utilized for hyperbaric oxygen treatment of carbon monoxide poisoning. J Emerg Med 1995; 13:227.</a></li><li><a class="nounderline abstract_t">Huang CC, Ho CH, Chen YC, et al. Hyperbaric Oxygen Therapy Is Associated With Lower Short- and Long-Term Mortality in Patients With Carbon Monoxide Poisoning. Chest 2017; 152:943.</a></li><li><a class="nounderline abstract_t">Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347:1057.</a></li><li><a class="nounderline abstract_t">Ducassé JL, Celsis P, Marc-Vergnes JP. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation? Undersea Hyperb Med 1995; 22:9.</a></li><li><a class="nounderline abstract_t">Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust 1999; 170:203.</a></li><li><a class="nounderline abstract_t">Raphael JC, Elkharrat D, Jars-Guincestre MC, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; 2:414.</a></li><li><a class="nounderline abstract_t">Juurlink DN, Buckley NA, Stanbrook MB, et al. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2005; :CD002041.</a></li><li><a class="nounderline abstract_t">Annane D, Chadda K, Gajdos P, et al. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med 2011; 37:486.</a></li><li><a class="nounderline abstract_t">Buckley NA, Juurlink DN, Isbister G, et al. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2011; :CD002041.</a></li><li><a class="nounderline abstract_t">Baran DA, Stelling K, McQueen D, et al. Pediatric Veno-Veno Extracorporeal Membrane Oxygenation Rescue From Carbon Monoxide Poisoning. Pediatr Emerg Care 2020; 36:e592.</a></li><li><a class="nounderline abstract_t">McCunn M, Reynolds HN, Cottingham CA, et al. Extracorporeal support in an adult with severe carbon monoxide poisoning and shock following smoke inhalation: a case report. Perfusion 2000; 15:169.</a></li><li><a class="nounderline abstract_t">Teerapuncharoen K, Sharma NS, Barker AB, et al. Successful Treatment of Severe Carbon Monoxide Poisoning and Refractory Shock Using Extracorporeal Membrane Oxygenation. Respir Care 2015; 60:e155.</a></li><li><a class="nounderline abstract_t">Wang GS, Levitan R, Wiegand TJ, et al. Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol 2016; 12:95.</a></li><li><a class="nounderline abstract_t">Rudge FW. Carbon monoxide poisoning in infants: treatment with hyperbaric oxygen. South Med J 1993; 86:334.</a></li><li><a class="nounderline abstract_t">Meert KL, Heidemann SM, Sarnaik AP. Outcome of children with carbon monoxide poisoning treated with normobaric oxygen. J Trauma 1998; 44:149.</a></li><li><a class="nounderline abstract_t">Kim JK, Coe CJ. Clinical study on carbon monoxide intoxication in children. Yonsei Med J 1987; 28:266.</a></li><li><a class="nounderline abstract_t">Cho CH, Chiu NC, Ho CS, Peng CC. Carbon monoxide poisoning in children. Pediatr Neonatol 2008; 49:121.</a></li><li><a class="nounderline abstract_t">Waisman D, Shupak A, Weisz G, Melamed Y. Hyperbaric oxygen therapy in the pediatric patient: the experience of the Israel Naval Medical Institute. Pediatrics 1998; 102:E53.</a></li><li><a class="nounderline abstract_t">Koren G, Sharav T, Pastuszak A, et al. A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy. Reprod Toxicol 1991; 5:397.</a></li><li><a class="nounderline abstract_t">Elkharrat D, Raphael JC, Korach JM, et al. Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy. Intensive Care Med 1991; 17:289.</a></li><li><a class="nounderline abstract_t">Arslan A. Hyperbaric oxygen therapy in carbon monoxide poisoning in pregnancy: Maternal and fetal outcome. Am J Emerg Med 2021; 43:41.</a></li><li><a class="nounderline abstract_t">Van Hoesen KB, Camporesi EM, Moon RE, et al. Should hyperbaric oxygen be used to treat the pregnant patient for acute carbon monoxide poisoning? A case report and literature review. JAMA 1989; 261:1039.</a></li><li><a class="nounderline abstract_t">Towers CV, Corcoran VA. Influence of carbon monoxide poisoning on the fetal heart monitor tracing: a report of 3 cases. J Reprod Med 2009; 54:184.</a></li><li><a class="nounderline abstract_t">Meng YH, Hsieh MS, Chi YC, et al. Effect of Carbon Monoxide Poisoning on Epilepsy Development: A Nationwide Population-Based Cohort Study. Ann Emerg Med 2023; 82:145.</a></li><li><a class="nounderline abstract_t">Henry CR, Satran D, Lindgren B, et al. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 2006; 295:398.</a></li><li><a class="nounderline abstract_t">Hampson NB, Courtney TG, Holm JR. Diffusion of carbon monoxide through gypsum wallboard. JAMA 2013; 310:745.</a></li></ol></div><div id="topicVersionRevision">Topic 322 Version 52.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36585319" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Morbidity and Mortality of Unintentional Carbon Monoxide Poisoning: United States 2005 to 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8037395" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Treatment of carbon monoxide poisoning: a critical review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7966524" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pathophysiology and treatment of carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18679118" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Risk factors for short-term mortality from carbon monoxide poisoning treated with hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27466698" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : U.S. Mortality Due to Carbon Monoxide Poisoning, 1999-2014. Accidental and Intentional Deaths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27753502" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37535036" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Carbon monoxide poisoning mortality in the United States from 2015-2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26032660" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Carbon monoxide poisoning deaths in the United States, 1999 to 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15660017" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Unintentional non-fire-related carbon monoxide exposures--United States, 2001-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034315" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Carbon monoxide poisoning from hurricane-associated use of portable generators--Florida, 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16628182" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Monitoring poison control center data to detect health hazards during hurricane season--Florida, 2003-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17976553" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Carbon monoxide poisoning during natural disasters: the Hurricane Rita experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15138958" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Carbon monoxide poisoning while using a small cooking stove in a tent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37816660" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Carbon Monoxide Levels Produced by Propane/Isobutane Canister Stoves inside a Tent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26032763" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Carbon Monoxide Poisoning from Portable Electrical Generators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15103294" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Carbon monoxide poisonings resulting from open air exposures to operating motorboats--Lake Havasu City, Arizona, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15470325" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Carbon monoxide releases and poisonings attributed to underground utility cable fires--New York, January 2000-June 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28484988" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Carbon Monoxide Poisoning from Hookah Smoking: An Emerging Public Health Problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32253946" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Comparison between carbon monoxide poisoning from hookah smoking versus other sources.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9828249" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10465248" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Diverse manifestations of oral methylene chloride poisoning: report of 6 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7016420" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cyanide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9559621" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9559621" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3726889" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Synergistic lethality induced by the combination of carbon monoxide and cyanide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14960423" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Carbon monoxide poisoning: undetected by both patients and their doctors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15474779" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9924492" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Carbon monoxide poisoning. Early awareness and intervention can save lives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2341364" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Carbon monoxide-mediated brain lipid peroxidation in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15862427" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cardiovascular manifestations of moderate to severe carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7710151" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6860181" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Delayed neurologic sequelae in carbon monoxide intoxication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14988368" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Delayed postanoxic encephalopathy after carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15796311" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Hyperbaric treatment of patients with carbon monoxide poisoning in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8437018" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Delayed neurological deterioration following carbon monoxide poisoning: MRI findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11942360" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diffusion-weighted MR imaging findings in carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13679276" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14752216" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Diffusion-weighted MRI and 99mTc-HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28753048" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Initial diffusion-weighted MRI and long-term neurologic outcomes in charcoal-burning carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15452310" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Hemorrhagic infarction in white matter following acute carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8037390" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Carbon monoxide controversies: neuropsychologic testing, mechanism of toxicity, and hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342916" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Delayed neuropathology after carbon monoxide poisoning is immune-mediated.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1180795" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : What is the mechanism of carbon monoxide toxicity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1328293" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9305585" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Vascular endothelial cells generate peroxynitrite in response to carbon monoxide exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10331130" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7710152" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Relationship between venous and arterial carboxyhemoglobin levels in patients with suspected carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10890654" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Relationship between arterial, mixed venous, and internal jugular carboxyhemoglobin concentrations at low, medium, and high concentrations in a piglet model of carbon monoxide toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9360570" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Confirmation of the pulse oximetry gap in carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2643368" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Pulse oximetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17065881" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21459480" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Accuracy of noninvasive multiwave pulse oximetry compared with carboxyhemoglobin from blood gas analysis in unselected emergency department patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27993310" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Carbon Monoxide Poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23513247" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Emergency department management of suspected carbon monoxide poisoning: role of pulse CO-oximetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23013097" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Falsely low carboxyhemoglobin level after hydroxocobalamin therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17210205" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17963990" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17963991" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clarifications regarding interference of hydroxocobalamin with carboxyhemoglobin measurements in victims of smoke inhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25089720" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Effects of hydroxocobalamin on carboxyhemoglobin measured under physiologic and pathologic conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16798147" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Carboxyhemoglobin measurement by hospitals: implications for the diagnosis of carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10713010" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17496229" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25997893" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A modern literature review of carbon monoxide poisoning theories, therapies, and potential targets for therapy advancement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6435739" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Delayed hyperbaric oxygen treatment for acute carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6435739" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Delayed hyperbaric oxygen treatment for acute carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9784458" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Hyperbaric oxygen therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15682684" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effects of carbon monoxide poisoning on neutrophil responses in patients treated with hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8248932" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7775795" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Selection criteria utilized for hyperbaric oxygen treatment of carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28427969" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Hyperbaric Oxygen Therapy Is Associated With Lower Short- and Long-Term Mortality in Patients With Carbon Monoxide Poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12362006" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Hyperbaric oxygen for acute carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7742714" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10092916" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2569600" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15674890" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Hyperbaric oxygen for carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21125215" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21491385" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Hyperbaric oxygen for carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29698335" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Pediatric Veno-Veno Extracorporeal Membrane Oxygenation Rescue From Carbon Monoxide Poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10789573" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Extracorporeal support in an adult with severe carbon monoxide poisoning and shock following smoke inhalation: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25922545" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Successful Treatment of Severe Carbon Monoxide Poisoning and Refractory Shock Using Extracorporeal Membrane Oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26013746" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8451675" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Carbon monoxide poisoning in infants: treatment with hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9464764" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Outcome of children with carbon monoxide poisoning treated with normobaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3439195" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Clinical study on carbon monoxide intoxication in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19054917" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Carbon monoxide poisoning in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9794983" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Hyperbaric oxygen therapy in the pediatric patient: the experience of the Israel Naval Medical Institute.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1806148" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1939875" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33497969" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Hyperbaric oxygen therapy in carbon monoxide poisoning in pregnancy: Maternal and fetal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2644457" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Should hyperbaric oxygen be used to treat the pregnant patient for acute carbon monoxide poisoning? A case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19370905" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Influence of carbon monoxide poisoning on the fetal heart monitor tracing: a report of 3 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36797130" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Effect of Carbon Monoxide Poisoning on Epilepsy Development: A Nationwide Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16434630" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23989964" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Diffusion of carbon monoxide through gypsum wallboard.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
